Allspring Global Investments Holdings, LLC Bridge Bio Pharma, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.4 Billion
- Q2 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 4,521 shares of BBIO stock, worth $114,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,521
Previous 4,568
1.03%
Holding current value
$114,064
Previous $141,000
19.15%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$784 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$634 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$355 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$314 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$153 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.74B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...